Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: JONAHLOMU

In that case my initial reaction is that the unbridled emotions of frustrated shareholders have been used as a leveraging tool.

I also think that the absence of CM was the main reason for TPL being unable to resolve what appeared to be relatively simple issues with both the '584 and the '336.

Share
New Message
Please login to post a reply